Importance of natural killer cells in the rejection of hamster skin xenografts

Transplantation

Volumn 65, Issue 5, 1998, Pages 727-734

  Gourlay, William A ^a   Chambers, William H ^b   Monaco, Anthony P ^a   Maki, Takashi ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; RAPAMYCIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL MEDIATED LYMPHOLYSIS; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; HAMSTER; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MIXED LYMPHOCYTE REACTION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN GRAFT; XENOGRAFT;

ANIMALS; ANTILYMPHOCYTE SERUM; CRICETINAE; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MESOCRICETUS; RATS; RATS, INBRED LEW; SKIN TRANSPLANTATION; SPLEEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032521054     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803150-00021     Document Type: Article

References (36)

1. Auchincloss H Jr. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
2. Nielsen B, Steinbruchel DA, Lillevang ST, Kemp E. Evidence for a primarily humoral rejection mechanism in concordant xenogeneic heart transplantation: a sequential immunohistological study in a hamster to rat model. APMIS 1993; 101: 587.
3. Nielsen B, Steinbruchel DA, Kemp E. An ultrastructural analysis of concordant and discordant cardiac xenografts in unmodified recipients: a sequential study in rodents with special reference to endothelial cell changes in the microvascular system. APMIS 1994; 102: 197.
4. Murase N, Starzl TE, Demetris AJ, et al. Hamster to rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993; 55: 701.
5. Gourlay W, Maki T, Monaco AP. Rejection of hamster skin xenografts by rats in the absence of anti-hamster antibody formation. Xenotransplantation 1997; 4: 49.
6. Torgersen KM, Salcedo M, Vaage JT, et al. Major histocompatibility complex class I independent killing of xenogeneic targets by rat allospecific natural killer cells. Transplantation 1997; 63: 119.
7. Sharabi Y, Aksentijevich I, Sundt TM III, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.
8. Blakely ML, van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
9. Inverardi L, Samaja M, Motterlini R, Mangili F, Bender JR, Pardi R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992; 149: 1416.
10. Thomas FT, Marchman A, Carrobi D, Araneda W, Pryor J, Thomas J. Immunobiology of the xenograft response: xenograft rejection in immunodeficient animals. Transplant Proc 1991; 23: 208.
11. Clave E, Socie G, Cosset JM, et al. Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation. Int J Radiat Oncol Biol Phys 1995; 33: 881.
12. Lebrec H, Roger R, Blot C, Burleson GR, Bohuon C, Pallardy M. Immunotoxicological investigation using pharmaceutical drugs: in vitro evaluation of immune effects using rodent or human immune cells. Toxicology 1995; 96: 147.
13. Loughran TP Jr, Deeg HJ, Storb R. Inhibition of canine NK activity by anti-CD18 monoclonal antibody, UV irradiation and cyclosporine. Exp Hematol 1993; 21: 411.
14. Luo H, Chen H, Daloze P, Wu J. Effects of rapamycin on human HLA unrestricted cell killing. Clin Immunol Immunopathol 1992; 65: 60.
15. Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB, Hiserodt JC. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine activated killer cells. J Exp Med 1989; 169: 1373.
16. van den Brink MRM, Hunt LE, Hiserodt JC. In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med 1990; 171: 197.
17. Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC, Trucco M. NKR-P1, a signal transduction molecule on natural killer cells. Science 1990; 249: 1298.
18. Bezouska K, Yuen CT, O'Brien J, et al. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994; 372: 150.
19. Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol 1990; 144: 251.
20. Kimball PM, Kerman RH, Kahan BD. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine. Transplantation 1991; 51: 486.
21. Metcalfe SM, Richards FM. Cyclosporine, FK506 and rapamycin: some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. Transplantation 1990; 49: 798.
22. Kay JE, Kromwel L, Doe SEA, Denyer M. Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology 1991; 72: 544.
23. Aagaard-Tillery KM, Jelinek DF. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol 1994; 156: 493.
24. Gray JG, Monaco AP, Wood ML, Russell PS. Studies on heterologous antilymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol 1966; 96: 217.
25. Bobbio SA, Wood ML, Monaco AP. Significant augmentation of specific unresponsiveness by sirolimus in ALS-treated, bone marrow injected mice. Transplant Sci 1993; 3: 51.
26. Sjogren HO, Hellstrom I. Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells. Exp Cell Res 1965; 40: 208.
27. Valdivia LA, Monden M, Gotoh M, Nakano Y, Tono T, Mori T. Evidence that deoxyspergualin prevents sensitization and first set cardiac xenograft rejection in rats by suppression of antibody formation. Transplantation 1990; 50: 132.
28. Chong ASF, Shen J, Xiao F, et al. Delayed xenograft rejection in the concordant hamster heart into lewis rat model. Transplantation 1996; 62: 90.
29. Miyazawa H, Murase N, Demetris AJ, et al. Hamster to rat kidney transplantation. Effects of FK506, cyclophosphamide, organ perfusion and complement inhibition. Transplantation 1995; 59: 1183.
30. Morris RE. Rapamycins: antifungal, antitumor, antiproliferative and immunosuppressive macrolides. Transplant Rev 1992; 6: 39.
31. Arakawa K, Akami T, Okamoto M, et al. Prolongation of heart xenograft survival in the NK deficient rat. Transplant Proc 1994; 26: 1266.
32. Thomas F, Araneda D, Henretta J, Pittman K, Marchman W. Extended and expanded studies of xenograft rejection in immunodeficient animals. Transplant Proc 1994; 26: 1224.
33. Nishimura Y, Eto E, Maeda T, et al. Inhibition of skin xenograft rejection by depleting T cell receptor αβ-bearing cells without T cell receptor γδ-bearing cells or natural killer cells by monoclonal antibody. Immunology 1994; 83: 196.
34. Maki T, O'Neil JJ, Porter J, Mullon CJP, Solomon BA, Monaco AP. Porcine islets for xenotransplantation. Transplantation 1996; 61: 136.
35. Karlsson-Parra A, Ridderstad A, Wallgren AC, Moller E, Ljunggren HG, Korsgren O. Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell depleted mice. Transplantation 1996; 61: 1313.
36. Morris CF, Simeonovic CJ, Fung MC, Wilson JD, Hapel AJ. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. J Immunol 1995; 154: 2470.